Is GSSC a good investment?

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) is a US small-cap ETF. As of September 11, 2026, ETF Copilot scores GSSC 4.5 out of 10 — highest on Valuation (7.8), lowest on Quality (1.4). It trades at 16.0 times earnings, against its own median of 16.0. Its ten largest holdings are 4% of the fund.

Updated September 11, 2026

How is GSSC rated? ETF Copilot scores Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) 4.5 out of 10

As of September 11, 2026, ETF Copilot scores Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) 4.5 out of 10 overall.

ETF Copilot scores (0–10 scale, higher is better):

Overall: 4.5 / 10
Growth: 5.0 / 10
Valuation: 7.8 / 10
Risk: 3.9 / 10
Quality: 1.4 / 10
Return: 4.4 / 10

GSSC is ranked #6 of 10 in ETF Copilot's Value list.

What is GSSC's expense ratio? 0.20% a year

As of September 11, 2026, GSSC charges 0.20% a year, yields 1.29% and holds $1.1B in assets across 1385 positions.

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) — cost, income and size
Measure	GSSC
Expense ratio	0.20%
Dividend yield	1.29%
Assets under management	$1.1B
Holdings	1385

Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.

What stands out in GSSC's data

U.S. small-cap stocks, picked through a multi-factor model.

Trades cheaper than most small-cap peers — you pay less for each dollar of earnings.

Trailing P/E multiple of 16.0x ranks among the cheapest 10% of small-cap funds, versus a 16.9x category median. The 0.20% expense ratio also runs below average.

A multi-factor tilt on small-cap value, built for portfolios seeking a price advantage.

Why did GSSC move this week? It fell 1.8% in the week to September 11, 2026 — Biocryst Pharm and Bancorp drove it

GSSC fell 1.8% in the week to September 11, 2026. The holdings that moved it most were Biocryst Pharm (−19.5%), Bancorp (−25.3%) and Appian (−14.8%); 10X Genomics (+8.5%) pushed the other way.

Is GSSC expensive right now? It trades at 16.0 times earnings, against its own median of 16.0

As of September 11, 2026, GSSC is more expensive than 50% of its own 111 monthly readings since 2017 — 56 of those months were cheaper than today.

Trailing twelve-month, computed by ETF Copilot from the fund's holdings rather than quoted from a data provider, and rebuilt nightly.

What's inside GSSC? 15% Tech

What's inside GSSC: Size (Large 0%, Mid 21%, Small 78%); Geography (International 7%, US 93%); Tech 15.0%; AI 0.4%; Semiconductors 1.9%; Memory 0.2%.

What are GSSC's top holdings? The ten largest are 4% of the fund

10X Genomics, Caredx, Travere Therapeutics, Alkermes, Enova International, Brightsphere Investment, Zeta Global, Stonex, Dave and Atricure are GSSC's largest holdings, in that order.

Less concentrated than 99% of US Small Cap ETFs.

Half of GSSC's weight sits in its 323 largest positions, and once those weights are taken into account it behaves like 847 equally weighted holdings.

Cite this

ETF Copilot, “Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF (GSSC) scores and holdings analysis”, as of September 11, 2026.
https://etf-copilot.com/etf/gssc